￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

What will the approximate medical insurance price of nintedanib be in 2025?

2026-02-01 22:25:32

Check Details
Analysis of the real efficacy and side effects of Adagrasib in KRAS mutated non-small cell lung cancer, and price purchase channels at home and abroad

2026-02-01 22:25:32

Check Details
Safety data sharing of Platinib (Pujihua) in patients of different ages

2026-02-01 22:25:32

Check Details
Analysis of the effect and applicable population of capmatinib (Tourad) postoperative adjuvant therapy

2026-02-01 22:25:32

Check Details
Sotorasib (AMG 510) vs immunotherapy: Which is better for KRAS mutations?

2026-02-01 22:25:32

Check Details
Clinical data analysis of how long adagrasib (Krazati) can prolong survival after taking it

2026-02-01 22:25:32

Check Details
Content analysis and key medication information of Pimitespib instructions

2026-02-01 22:25:32

Check Details
Comparison of the differences and advantages between domestic and imported versions of Afatinib

2026-02-01 22:25:32

Check Details
Detailed explanation of domestic pricing and medical insurance coverage of Daridorexant

2026-02-01 22:25:32

Check Details
Comparative analysis of the characteristics of olaparib (lipadro) targeted drug and chemotherapy drugs

2026-02-01 22:25:32

Check Details
Analysis of indications and clinical application population of Venetoclax/Venetoclax (Vekela)

2026-02-01 22:25:32

Check Details
Detailed instructions and medication instructions for Asnib/Assiminib (Xinbeli)

2026-02-01 22:25:32

Check Details
Category
相关知识